Lung Cancer

Our generational commitment to driving scientific innovation is reflected by our robust pipeline of cancer cell-directed and immune-oncology investigational therapies, as well as the smart combination of these approaches. Boehringer Ingelheim is taking a diligent and broad approach, creating a collaborative research network to tap into a diversity of minds, which is vital in addressing some of the most challenging, but potentially most impactful, areas of cancer research.